menu
    • menu

    Company profile for ImmunityBio

    NEW Drugs in Dev: 45
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Inducing Immunogenic Cell Death By Orchestrating the Innate (NK) and Adaptive (T Cell) Immune System. ImmunityBio, Inc. is a privately held immunotherapy company with one of the broadest portfolios of biological molecules spanning albumin-linked chemotherapeutic, peptides, fusion proteins, cytokine, monoclonal antibodies, adenovirus and yeast vaccine therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ImmunityBioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Culver City, CA 90232
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://immunitybio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/immunitybio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Immunitybio Unveils Lung And Bladder Cancer Data At ASCO 2026
    Immunitybio Unveils Lung And Bladder Cancer Data At ASCO 2026

    01 Jun 2026

    // PRESS RELEASE

    https://ir.immunitybio.com/news-releases/news-release-details/immunitybio-presents-new-clinical-and-comparative-data-across?field_nir_news_date_value[min]=

    PRESS RELEASE
    01 Jun 2026
    Share Share
    ImmunityBio Presents ANKTIVA Cost-Effectiveness at ISPOR 2026
    ImmunityBio Presents ANKTIVA Cost-Effectiveness at ISPOR 2026

    22 May 2026

    // PRESS RELEASE

    https://ir.immunitybio.com/news-releases/news-release-details/immunitybio-presents-health-economic-analysis-ispor-2026-showing

    PRESS RELEASE
    22 May 2026
    Share Share
    ImmunityBio: UK Patients with NMIBC Favor Bladder Preservation
    ImmunityBio: UK Patients with NMIBC Favor Bladder Preservation

    22 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-22/immunitybio-highlights-patient-survey-data-at-ispor-2026-showing-majority-of-uk-adults-living-with-n

    PHARMIWEB
    22 May 2026
    Share Share
    ImmunityBio Presents ANKTIVA Cost-Effectiveness Data at ISPOR'26
    ImmunityBio Presents ANKTIVA Cost-Effectiveness Data at ISPOR'26

    22 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260522861965/en/ImmunityBio-Presents-Health-Economic-Analysis-at-ISPOR-2026-Showing-ANKTIVA-Plus-BCG-Delivers-Lower-Cost-per-Sustained-Complete-Response-Versus-TAR-200-in-BCG-Unresponsive-NMIBC-CIS

    BUSINESSWIRE
    22 May 2026
    Share Share
    ImmunityBio Gets FDA sNDA Acceptance for ANKTIVA Plus BCG
    ImmunityBio Gets FDA sNDA Acceptance for ANKTIVA Plus BCG

    20 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-20/immunitybio-announces-fda-acceptance-of-supplemental-bla-for-anktiva-plus-bcg-in-bcg-unresponsive-n

    PHARMIWEB
    20 May 2026
    Share Share
    ImmunityBio Presents Comparative Data on NAI Plus BCG at AUA 2026
    ImmunityBio Presents Comparative Data on NAI Plus BCG at AUA 2026

    19 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-19/immunitybio-presents-favorable-comparative-effectiveness-data-in-complete-response-rates-of-nai-plus-bc

    PHARMIWEB
    19 May 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search